Intended for healthcare professionals

CCBY Open access
Research

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1849 (Published 14 May 2020) Cite this as: BMJ 2020;369:m1849

Read our latest coverage of the coronavirus pandemic

Linked Editorial

Lack of efficacy of hydroxychloroquine in covid-19

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: May 2020 to September 2024

Rendering graph...
AbstractFullPdf
May 202010020157512642
Jun 202045205793506
Jul 202056147271815
Aug 202064101381535
Sep 2020454635880
Oct 2020244375695
Nov 2020203066484
Dec 2020222758403
Jan 2021203265397
Feb 202192167238
Mar 202162762435
Apr 2021102270325
May 202112211340
Jun 202152125349
Jul 202141633203
Aug 202161859209
Sep 202151919241
Oct 202151719241
Nov 202141395187
Dec 202161633154
Jan 202262185167
Feb 2022222131161
Mar 202272024172
Apr 2022121801213
May 2022191543132
Jun 2022151528119
Jul 2022151526158
Aug 2022161798139
Sep 2022122751134
Oct 202210122193
Nov 202211133593
Dec 202213112597
Jan 20231399681
Feb 2023111221102
Mar 2023121193102
Apr 2023221184133
May 20231299366
Jun 202322101365
Jul 20231291059
Aug 202310107877
Sep 202391277121
Oct 202313139989
Nov 202311116578
Dec 202381023121
Jan 2024141053135
Feb 2024141486115
Mar 20241151055121
Apr 2024155995101
May 202413995172
Jun 202412566065
Jul 202410670062
Aug 202411366774
Sep 20242615521
Total157732895328817